Choline Magnesium Trisalicylate

[17 October 2016]

Products Affected - Description

Choline Magnesium Trisalicylate, Marlex
500 mg tablets, 100 count (NDC 10135-0467-01)
750 mg tablets, 100 count (NDC 10135-0468-01)
Choline Magnesium Trisalicylate - Silarx
500 mg/5 mL liquid, 240 mL (NDC 54838-0522-70)

Reason for the Shortage

  • Marlex discontinued choline magnesium trisalicylate tablets in 2016.
  • Silarx discontinued choline magnesium trisalicylate liquid in July 2016.

Available Products

There are no presentations available.

Estimated Resupply Dates

  • Marlex discontinued their choline magnesium trisalicylate tablets.
  • Silarx discontinued their choline magnesium trisalicylate liquid.

Related Shortages


October 17, 2016; April 27 and February 18, 2015; December 3, September 8, June 3, March 24, January 29, 2014; October 7, September 13, August 8, May 30, February 27, 2013; November 27, August 30, June 20, March 15, 2012; December 16, September 21, July 20, April 28, February 23, January 5, 2011; October 25, August 6, June 16, May 14, March 17, February 12, January 20, 2010; December 9, November 18, October 28, September 14, August 11, July 28, 2009. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
ASHP Product Listing